Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Aura Biosciences, Inc. (AURA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
12.11+0.90 (+8.03%)
At close: 04:00PM EST
11.75 -0.36 (-2.97%)
After hours: 05:54PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close11.21
Open11.11
Bid11.88 x 1100
Ask12.14 x 1300
Day's Range11.06 - 12.31
52 Week Range9.43 - 24.83
Volume78,869
Avg. Volume111,713
Market Cap448.551M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.11
Earnings DateNov 10, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est31.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AURA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aura Biosciences, Inc.
    Daily – Vickers Top Buyers & Sellers for 01/18/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • Simply Wall St.

    Institutional investors may adopt severe steps after Aura Biosciences, Inc.'s (NASDAQ:AURA) latest 11% drop adds to a year losses

    A look at the shareholders of Aura Biosciences, Inc. ( NASDAQ:AURA ) can tell us which group is most powerful. And the...

  • Insider Monkey

    12 Stocks Insiders are Buying Now

    In this article, we will look at the 12 stocks insiders are buying now. If you want to explore similar stocks, you can also take a look at 5 Stocks Insiders are Buying Now. Investing in stocks that insiders are buying can sometimes lead to unexpected gains. Insiders, such as company executives, board members, and major […]

  • Business Wire

    Aura Biosciences Announces Pricing of Public Offering of Common Stock

    BOSTON, December 01, 2022--Aura Biosciences, Inc. ("Aura") (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an underwritten public offering of 6,700,000 shares of its common stock at a price to the public of $12.00 per share. The gross proceeds from the offering to Aura are expected to be $80.4 million, before deducting underwriting discounts and commissio

Advertisement
Advertisement